The University of Chicago Medicine broke ground Tuesday on its $815 million project to build the state’s first and only standalone structure dedicated to cancer care and research. The 575,000-square-foot, seven-story pavilion builds off the University of Chicago’s decades of work and leadership in cancer research and its prestigious designation as a Comprehensive Cancer Center.
The September 19 event included remarks from Chicago Mayor Brandon Johnson, Attorney General Kwame Raoul and University of Chicago and health system leaders. It also featured performances by the Chicago Mass Choir and a ceremonial bell ringing that evoked the long-standing patient tradition that marks the end of successful oncology treatments.
The academic health system seeks to dramatically improve the experience for patients with cancer, reduce health disparities in underserved communities and speed up scientific discoveries through the freestanding pavilion, which will be built on its flagship campus in the Hyde Park neighborhood on the South Side.
“This project represents our latest bold move to make an even bigger difference in cancer care and research,” said Tom Jackiewicz, President of the University of Chicago Health System, which is known in the marketplace as UChicago Medicine. “This new pavilion will advance scientific discovery so that we can find cures, shape the future of oncology care and treatment, and reduce the cancer burden in the communities that we serve.”
Expected to open to patients in spring 2027, the building will allow UChicago Medicine’s nationally recognized clinicians, physician-scientists and researchers to better collaborate with colleagues across the University of Chicago. The team of more than 200 people currently works in more than five different buildings on the Hyde Park campus. The new facility will be the central point of cancer research efforts, new therapy development, clinical advancements and other discoveries.
Click here to read the full story.
This story was first published by UChicago Medicine.
